Tirzepatide represents the next generation of incretin-based therapy and is considered a novel dual agonist of GLP-1 and GIP receptors
December 18, 2023: Recently, a federal judge in Louisiana partially denied Novo Nordisks request to dismiss an Ozempic lawsuit filed by a woman who alleges the medication failed to warn about its side effects, particularly gastroparesis
The results showed that the expression of KIM-1 in the tubular cells was upregulated after FA injection, while the effect was blocked by LA supplementation
Hitting a weight loss plateau is frustrating
Signs of degradation Watch for these warning signs in reconstituted solution: Cloudiness or turbidity that was not present immediately after reconstitution Visible particles floating in the solution Color change from clear to yellow, amber, or any other tint Gel-like consistency or increased viscosity Unusual odor that was not present before Any of these signs suggest that the peptide has degraded, the solution has been contaminated, or both